| Variables | Controlling for Precancer Characteristics | Controlling for Precancer Characteristics, Depressive Symptoms, and Length of Time with Provider | |||||
|---|---|---|---|---|---|---|---|
| No Cancer | Cancer Overall | <5 Years from Diagnosis | ≥5 Years from Diagnosis | No Cancer | <5 Years from Diagnosis | ≥5 Years from Diagnosis | |
| Cancer screening of all particpants† | |||||||
| Pelvic exam or Pap smear | 61 (59–63) | 70 (63–76) | 71 (63–82) | 68 (57–76) | 61 (59–63) | 72 (64–82) | 68 (58–76) |
| Mammogram | 76 (74–77) | 86 (78–90) | 87 (78–92) | 86 (78–92) | 76 (74–77) | 87 (78–92) | 86 (77–92) |
| Prostate exam | 69 (67–71) | 76 (70–82) | 79 (69–85) | 72 (62–81) | 69 (67–71) | 78 (68–84) | 72 (60–81) |
| Cancer screening excluding participants associated with cancer | |||||||
| Pelvic exam or Pap smear | 61 (59–63) | 69 (63–76) | 71 (63–82) | 67 (56–75) | 61 (59–63) | 72 (63–82) | 66 (56–75) |
| Mammogram | 76 (74–77) | 80 (69–86) | 76 (58–87) | 83 (72–93) | 76 (74–77) | 76 (57–86) | 82 (71–93) |
| Prostate exam | 69 (67–71) | 69 (57–77) | 67 (53–80) | 72 (58–84) | 69 (67–71) | 65 (50–79) | 72 (57–84) |
Values provided as percent (95% confidence interval).
Sample sizes for participants with and without cancer are indicated in Table 3.
↵* All models adjusted for variables as described in Table 1. Bold values indicate comparisons that were significant in the logistic regression model (p < .05) that compared screening behavior in participants with and without cancer.
↵† Pelvic/Pap and mammogram for women only, prostate exam for men only.